Cas:849924-48-7 (s)-1-{(r)-2-[bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5 manufacturer & supplier

We serve Chemical Name:(s)-1-{(r)-2-[bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5 CAS:849924-48-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(s)-1-{(r)-2-[bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5

Chemical Name:(s)-1-{(r)-2-[bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5
CAS.NO:849924-48-7
Synonyms:(s)-1-{(r)-2-[bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5
Molecular Formula:C46H52FeO2P2
Molecular Weight:754.69600
HS Code:29319090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:45.64000
Exact Mass:754.27900
LogP:10.46750

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like (s)-1-{(r)-2-[bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(s)-1-{(r)-2-[bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(s)-1-{(r)-2-[bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5 Use and application,(s)-1-{(r)-2-[bis(4-methoxy-3,5-dimethylphenyl)phosphino]ferrocenyl}-ethyldi(3,5 technical grade,usp/ep/jp grade.


Related News: Importance of evaluating biocatalytic processes during development 1-[(4-chloro-5-methoxy-2,7-dimethyl-indol-3-yl)-oxo-acetyl]-2,5-dihydro-pyrrole manufacturers Symonds’ board has backed Walmsley’s leadership. In response to Elliott’s open attack earlier this month, the GSK board said it “strongly believes” Walmsley is the “right leader” for the company, citing “widespread and strong support” from GSK’s largest shareholders for Walmsley’s newly unveiled plan to improve the company’s performance. (R)-1-((benzyloxy)methyl)-5-((S)-1-hydroxyprop-2-yn-1-yl)pyrrolidin-2-one suppliers With the closing of AstraZeneca’s mega $39 billion buyout of Alexion Pharmaceuticals this week, the U.K. pharma has officially picked up Soliris and its successor, Ultomiris. tert-butyl (3R,4R)-N-tert-butyloxycarbonyl-4-aminopyrrolidine-3-carboxylate vendor & factory.